OS Therapies logo

OS Therapies

OSTX | AMEX
Chart Builder DCF Calculator
$0.68
-$0.06 (-8.72%)
At close: Nov 16, 2026, 4:00 PM ET
$0.68
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:55 PM ET
-8.72%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
21
-9.0 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #984/1021 (Top 96%)

Key Statistics

Market Data

Market Cap $31.86M
1D Range
0.67 0.75
52W Range
0.67 2.24

Valuation (TTM)

PE -0.62
PB -0.00
EV/EBITDA N/A

Valuation (NTM)

Forward PE N/A
Forward PEG -0.10
Price Target $16.50
Loading financial charts...

Profile

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the Un...

Sector Healthcare
Industry Biotechnology
Employees 5
IPO Date Aug 1, 2024
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Nov 16, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$16.50
Upside
+2326.47%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.